British-Swedish pharmaceutical firm AstraZeneca Plc said on Tuesday that the previous day its unit AstraZeneca Finance LLC priced two tranches of Eurobonds worth a total of €1.4 billion ($1.5 billion). The company expects to use the net proceeds from the offering for general corporate purposes. The offering is expected to be closed on August 5. The offering comprises €650 million of fixed rate notes with a coupon of 3.121% maturing on August 5, 2030, and €750 million of fixed rate notes with a coupon of 3.278% maturing on August 5, 2033. BNP Paribas, Goldman Sachs International, Morgan Stanley…